Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inhaled drug delivery
Biotech
Synairgen ACTIV-2 trial paused while NIH tweaks study design
A day after axing a trial for SAB's COVID-19 antibody, the National Institutes of Health has placed Synairgen’s similar trial on hold, too.
Max Bayer
Mar 3, 2022 3:30pm
Synairgen's COVID-19 SPRINTER trial falls at final hurdle
Feb 22, 2022 7:05am
Inhalable antibody tamps down COVID-19 in hamsters
Oct 15, 2021 8:50am
Pulmocide eyes global phase 3 registration with fresh funds
May 26, 2021 2:47pm
Inhaled interferon doesn’t enhance COVID-19 entry point: study
Jan 11, 2021 11:00am
Inhaled antibody drug for COVID-19 clears coronavirus in animals
Oct 20, 2020 3:08pm
